Though this study, STEP Young, has not yet begun recruitment, it plans to follow children and teenagers for 132 weeks as they receive once weekly semaglutide to assess the medications effect on BMI
Byetta (exenatide) [package insert]
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications
For uninsured patients, self-pay options through PlexusDx represent the most financially sustainable path to proven GLP-1 weight loss therapy currently available in the marketplace
What makes it stand out is the combination of medical treatment and behavioral coaching in one platform
Bonus points: Theres an important caveat here, which is that fermentable fiber isnt good for everyone at all times in their healing journeys